Cite

HARVARD Citation

    Elseginy, S. et al. (2020). Design, synthesis, and computational validation of novel compounds selectively targeting HER2-expressing breast cancer. Bioorganic & medicinal chemistry letters. 30 (24), p. . [Online]. 
  
Back to record